Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women.
Clinical trial NCT06726850 · COMPLETED
Trial details
- NCT number
- NCT06726850
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-14
- Primary completion
- 2025-04-17
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.